These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8967725

  • 1. Molecular etiopathogenesis of esophageal cancers.
    Montesano R, Hollstein M, Hainaut P.
    Ann Ist Super Sanita; 1996; 32(1):73-84. PubMed ID: 8967725
    [Abstract] [Full Text] [Related]

  • 2. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma.
    Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SE.
    Cancer Res; 1995 Aug 01; 55(15):3406-11. PubMed ID: 7614480
    [Abstract] [Full Text] [Related]

  • 3. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
    Muzeau F, Fléjou JF, Potet F, Belghiti J, Thomas G, Hamelin R.
    Gastroenterol Clin Biol; 1996 Aug 01; 20(5):430-7. PubMed ID: 8761140
    [Abstract] [Full Text] [Related]

  • 4. Molecular precursor lesions in oesophageal cancer.
    Montesano R, Hainaut P.
    Cancer Surv; 1998 Aug 01; 32():53-68. PubMed ID: 10489623
    [Abstract] [Full Text] [Related]

  • 5. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
    Bennett WP, von Brevern MC, Zhu SM, Bartsch H, Muehlbauer KR, Hollstein MC.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 01; 6(11):963-6. PubMed ID: 9367071
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and gene expression in esophageal cancer.
    Xu XC.
    Methods Mol Biol; 2009 Nov 01; 471():335-60. PubMed ID: 19109788
    [Abstract] [Full Text] [Related]

  • 7. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R, Weissfeld JL, Reynolds JC, Kuller LH.
    Cancer Epidemiol Biomarkers Prev; 1997 May 01; 6(5):369-77. PubMed ID: 9149898
    [Abstract] [Full Text] [Related]

  • 8. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.
    Mod Pathol; 2001 May 01; 14(5):397-403. PubMed ID: 11353048
    [Abstract] [Full Text] [Related]

  • 9. The molecular biology of esophageal adenocarcinoma.
    Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN.
    J Surg Oncol; 2005 Dec 01; 92(3):169-90. PubMed ID: 16299787
    [Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP, Yang GY, Wang LD, Shi ST, Yang CS.
    Clin Cancer Res; 1999 May 01; 5(5):1231-40. PubMed ID: 10353761
    [Abstract] [Full Text] [Related]

  • 11. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
    Sepehr A, Tanière P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, Etemad-Moghadam G, Kamangar F, Saidi F, Hainaut P.
    Oncogene; 2001 Nov 01; 20(50):7368-74. PubMed ID: 11704866
    [Abstract] [Full Text] [Related]

  • 12. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.
    Montesano R, Hollstein M, Hainaut P.
    Int J Cancer; 1996 Jun 21; 69(3):225-35. PubMed ID: 8682592
    [Abstract] [Full Text] [Related]

  • 13. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A, Wierzchniewska-Ławska A, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E.
    Pol Merkur Lekarski; 2009 May 21; 26(155):385-9. PubMed ID: 19606680
    [Abstract] [Full Text] [Related]

  • 14. Vitamin intake and risk of subtypes of esophageal cancer in Germany.
    Bollschweiler E, Wolfgarten E, Nowroth T, Rosendahl U, Mönig SP, Hölscher AH.
    J Cancer Res Clin Oncol; 2002 Oct 21; 128(10):575-80. PubMed ID: 12384802
    [Abstract] [Full Text] [Related]

  • 15. The lack of association between adenocarcinoma of the esophagus and gastric surgery: a retrospective study.
    Birgisson S, Rice TW, Easley KA, Richter JE.
    Am J Gastroenterol; 1997 Feb 21; 92(2):216-21. PubMed ID: 9040194
    [Abstract] [Full Text] [Related]

  • 16. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 21; 14(3):620-5. PubMed ID: 15767340
    [Abstract] [Full Text] [Related]

  • 17. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India.
    Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC.
    Cancer Lett; 2005 Jan 31; 218(1):69-79. PubMed ID: 15639342
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M, Saure C, Pahl R, Schorr F, Rüschoff J, Alles JU, Heinmöller E.
    Pathol Res Pract; 2008 Jan 31; 204(5):285-94. PubMed ID: 18337019
    [Abstract] [Full Text] [Related]

  • 19. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U, Tannapfel A, Breitung B, Breidert M, Wittekind CW, Mössner J.
    Hepatogastroenterology; 2000 Jan 31; 47(34):962-6. PubMed ID: 11020858
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for esophageal cancer development.
    Falk GW.
    Surg Oncol Clin N Am; 2009 Jul 31; 18(3):469-85. PubMed ID: 19500737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.